Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital.
ESKAPE
Southern Italy
antimicrobial resistance
hospital units
Journal
Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
pubmed:
16
12
2021
medline:
27
4
2022
entrez:
15
12
2021
Statut:
ppublish
Résumé
This study evaluated the spread and possible changes in resistance patterns of ESKAPE bacteria to first-choice antibiotics from 2015 to 2019 at a third-level university hospital after persuasive stewardship measures were implemented. Isolates were divided into three groups (group 1, low drug-resistant; group 2, multidrug/extremely drug-resistant; and group 3, pan-resistant bacteria) and a
Identifiants
pubmed: 34910885
doi: 10.1089/mdr.2021.0109
pmc: PMC9058886
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
425-435Références
Hosp Top. 2021 Jul-Sep;99(3):140-150
pubmed: 33792522
Infect Drug Resist. 2019 Dec 03;12:3783-3795
pubmed: 31819559
Int J Antimicrob Agents. 2016 Jul;48(1):11-18
pubmed: 27256586
Minerva Anestesiol. 2015 Apr;81(4):405-18
pubmed: 25220548
Infect Drug Resist. 2021 Jun 14;14:2201-2212
pubmed: 34163185
Crit Care Med. 2015 Aug;43(8):1580-6
pubmed: 25855900
Epidemiol Prev. 2019 Mar-Jun;43(2-3):185-193
pubmed: 31293138
J Antimicrob Chemother. 2019 Nov 1;74(11):3399-3401
pubmed: 31369095
Am J Infect Control. 2014 Apr;42(4):393-400
pubmed: 24559594
Open Forum Infect Dis. 2019 Dec 12;6(12):ofz505
pubmed: 31858018
Nat Rev Microbiol. 2019 Jan;17(1):51-62
pubmed: 30333569
Int J Infect Dis. 2019 Jul;84:153-162
pubmed: 31204003
Microorganisms. 2020 Oct 21;8(10):
pubmed: 33096921
Open Forum Infect Dis. 2019 Feb 28;6(4):ofz110
pubmed: 31240236
Clin Microbiol Rev. 2020 May 13;33(3):
pubmed: 32404435
Clin Infect Dis. 2016 May 15;62(10):e51-77
pubmed: 27080992
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Infez Med. 2017 Jun 1;25(2):98-107
pubmed: 28603227
Clin Infect Dis. 2019 Jan 18;68(3):355-364
pubmed: 29893802
Infect Control Hosp Epidemiol. 2012 Jun;33(6):589-93
pubmed: 22561714
Clin Lab. 2021 Feb 1;67(2):
pubmed: 33616331
Infect Control Hosp Epidemiol. 2015 Dec;36(12):1458-60
pubmed: 26313707
Clin Microbiol Infect. 2018 Aug;24(8):865-870
pubmed: 29221995
EBioMedicine. 2019 Aug;46:184-192
pubmed: 31307955
Int J Infect Dis. 2020 Nov;100:497-506
pubmed: 32781161
Clin Infect Dis. 2009 Jan 1;48(1):1-12
pubmed: 19035777
Int J Antimicrob Agents. 2020 Mar;55(3):105891
pubmed: 31923569
Ann Intensive Care. 2020 Jul 13;10(1):94
pubmed: 32661791
Clin Infect Dis. 2018 Nov 28;67(12):1803-1814
pubmed: 30052813
Clin Infect Dis. 2020 Dec 3;71(9):e487-e496
pubmed: 31994704
Open Forum Infect Dis. 2020 Nov 06;7(11):ofaa452
pubmed: 33204753
J Antimicrob Chemother. 2001 Jul;48 Suppl 1:87-102
pubmed: 11420342
Clin Infect Dis. 2013 Jul;57(2):217-20
pubmed: 23580731
Infect Control Hosp Epidemiol. 2012 Apr;33(4):381-8
pubmed: 22418634
J Infect Dis. 2008 Apr 15;197(8):1079-81
pubmed: 18419525
BMC Infect Dis. 2021 Aug 12;21(1):806
pubmed: 34384380
BMC Infect Dis. 2016 Dec 12;16(1):747
pubmed: 27955639